Sipchem Loss Widens to 1.21B SAR in Nine Months

Riyadh, Saudi Arabia — Sahara International Petrochemical Company (Sipchem) reported a net loss of 1.21 billion SAR for the nine months ending September 30, 2026, a 173% deterioration from the 442.6 million SAR loss recorded in the same period last year. Supply chain disruptions, rising feedstock costs, and impairment charges on associate investments drove the sharp decline.

Revenue also fell, dropping 32.8% year-over-year to 3.52 billion SAR for the nine-month period, as lower sales volumes more than offset modest gains in average selling prices. Gross profit collapsed 90.4% to just 23.2 million SAR, leaving Sipchem with an operating loss of 433.6 million SAR — 16.6% wider than the same period in 2025.

Q3 2026: A Relative Improvement

The third quarter told a more encouraging story, at least in comparison. Sipchem posted a quarterly net loss of 401.6 million SAR, 14.3% smaller than the 468.7 million SAR loss in Q3 2025. Revenue climbed 5.1% year-over-year to 1.44 billion SAR, lifted by higher average selling prices despite continued volume weakness.

Sequentially, Q3 improved meaningfully. The net loss narrowed 32.2% from Q2’s 591.9 million SAR. Revenues surged 66.7% from the prior quarter, as volumes recovered and feedstock prices for ethylene and propane eased. However, the gross loss widened slightly to 28.9 million SAR from 25.9 million SAR in Q2, suggesting cost pressures remain stubborn.

Key Drivers

• Supply chain disruptions cut sales volumes throughout the nine-month period, limiting revenue despite price improvements.
• Feedstock costs — particularly butane, ethylene, and propane — rose sharply year-over-year, compressing margins.
• An impairment of 328 million SAR on an investment in an associate was recognized in Q2 2026.
• A further 171 million SAR impairment on a plant owned by an associate hit Q3 2026 results.
• In Q3 2025, Sipchem had absorbed a 100 million SAR impairment at International Diol Company and a 91.4 million SAR provision to discontinue certain capital projects — charges that did not recur this year.
• Total shareholders’ equity fell 13.9% year-over-year to 12.42 billion SAR.
• Loss per share stood at 1.67 SAR for the nine months, versus 0.61 SAR in the prior-year period.

What This Means for Investors

• Sipchem’s nine-month loss has nearly tripled year-over-year, driven by factors — associate impairments and supply chain disruption — that show no clear sign of resolution.
• Shareholders’ equity has eroded by nearly 2 billion SAR year-over-year, which will concern investors monitoring balance sheet health.
• The Q3 sequential recovery in revenue and loss reduction is a positive signal, but gross profit remains negative — meaning Sipchem is still selling products below production cost.
• The unmodified auditor’s conclusion provides assurance on reporting integrity, though the breadth and scale of impairment charges demand close scrutiny in coming quarters.

Saudi Arabia capital markets news and analysis

Latest investor news from the Saudi stock market

THE SAUDI STANDARD’S VIEW: SIPCHEM’S DEEPENING LOSSES TEST INVESTOR PATIENCE AND BALANCE SHEET RESILIENCE

Sipchem’s nine-month results for 2026 represent one of the more sobering financial disclosures from a major Saudi petrochemical producer this cycle. With losses nearly tripling year-over-year and gross profit reduced to a fraction of its former scale, investors must now assess whether the company’s difficulties reflect a temporary convergence of adverse conditions or a more structural deterioration in its competitive position within the Kingdom’s chemicals sector.

• IMPAIRMENT CHARGES SIGNAL DEEPER STRUCTURAL CONCERNS

The recognition of nearly 500 million SAR in impairment charges across two consecutive quarters — targeting associate investments and plant assets — goes well beyond routine write-downs. These charges suggest that the value embedded in Sipchem’s associate network has deteriorated materially, raising questions about the long-term viability of those partnerships. Investors should treat recurring impairments not as one-off events but as indicators of strategic misalignment within the company’s broader asset portfolio.

• GROSS PROFIT COLLAPSE REVEALS A COST STRUCTURE UNDER SIEGE

A 90.4% collapse in gross profit over nine months, leaving the company selling products below the cost of production, points to a feedstock cost structure that pricing power alone cannot repair. Even as average selling prices improved in Q3, gross losses widened sequentially — confirming that the revenue recovery is not yet translating into margin rehabilitation. Until butane, ethylene, and propane input costs normalize and supply chain efficiency is restored, operational profitability will remain elusive.

• EQUITY EROSION TIGHTENS THE FINANCIAL SAFETY MARGIN

A 13.9% year-over-year decline in shareholders’ equity to 12.42 billion SAR represents a significant reduction in the financial cushion available to absorb further losses or fund strategic repositioning. At a loss per share of 1.67 SAR for nine months alone, the pace of equity depletion warrants close monitoring by institutional investors evaluating their exposure. Should losses continue at this trajectory, questions around capital adequacy and potential balance sheet remediation will move from background concern to foreground priority.

• Q3 SEQUENTIAL RECOVERY IS REAL BUT FRAGILE

The 32.2% sequential narrowing of net losses in Q3, combined with a 66.7% surge in quarterly revenue, demonstrates that Sipchem retains meaningful operational elasticity when conditions partially relent. However, this recovery rests on a narrow foundation of easing feedstock prices and volume normalization — factors outside management’s direct control. Investors should weight these improvements cautiously until the company demonstrates sustained positive gross margins over multiple consecutive quarters.

Sipchem’s predicament carries broader relevance for Saudi Arabia’s industrial diversification agenda under Vision 2030. The Kingdom’s ambition to position itself as a global chemicals and advanced materials hub depends on the financial health and competitive resilience of anchor producers like Sipchem. A prolonged loss cycle at a company of this scale underscores the urgency of accelerating feedstock efficiency programs, deepening downstream integration, and strengthening the operational governance of associate entities — strategic imperatives that extend far beyond any single earnings cycle.